Table 1.
Untreated |
DHA treated |
|||
---|---|---|---|---|
Sham | Heart failure | Sham | Heart failure | |
Body mass (g) | 411±8 | 390±7 | 437±5 | 403±7 |
Atria mass (mg) | 57±5 | 210±13* | 61±4 | 189±14* |
RV mass (mg) | 198±7 | 413±12* | 225±7 | 374±19* |
LV mass (mg) | 876±18 | 1,282±34* | 943±19 | 1,298±39* |
Echocardiography: | ||||
Heart rate (bpm) | 359±7 | 342±5 | 349±12 | 337±5 |
End Diastolic Diameter (mm) | 7.5±0.2 | 8.3±0.2# | 7.7±0.2 | 8.4±0.2# |
End Systolic Diameter (mm) | 4.3±0.2 | 5.9±0.2* | 4.3±0.2 | 5.4±0.2* |
End Diastolic Volume (μL) | 494±47 | 641±42* | 470±55 | 625±47# |
End Systolic Volume (μL) | 90±20 | 228±17* | 96±22 | 183±19# |
Ejection Fraction (%) | 81.9±2.1 | 64.2±1.8* | 81.0±2.3 | 71.5±1.8#† |
P <0.001
P <0.05 compared to sham within the same dietary group,
P <0.01 vs. the untreated heart failure group
Groups sizes were 15 and 20 for the untreated sham and heart failure groups, respectfully, and 14 and 20 for the DHA treated sham and heart failure groups, respectfully